Oncology Clinical Trials in Austin, TX

As of September 2026, 116 paid clinical trials are recruiting for Oncology in Austin, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in Austin

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

for Non-Hodgkin Lymphoma

1 location in Austin

Sponsor: Natera, Inc.

Sex: All·Age: 18+

Code: NCT07750886·Recruiting·Listed Aug 6, 2026

Apply to this trial

A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors

for Solid Tumor

Sites in Austin & San Antonio

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07703878·Phase 1·Recruiting·Listed Jul 15, 2026

Apply to this trial

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for AML

Sites in Austin, Houston +24 more locations

Sponsor: TScan Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07702578·Phase 3·Recruiting·Listed Jul 14, 2026

Apply to this trial

119 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Austin, TX.

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for Urothelial Cancer

Drug: PF-08634404

Sites in Austin, Waco +131 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for Non-small Cell Lung Cancer (NSCLC)

Drug: Durvalumab

Sites in Austin, San Antonio +35 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07361497·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Advanced Non-Small Cell Lung Cancer

Drug: PF-08634404

Sites in Austin, Waco +204 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for Carcinoma, Renal Cell

Drug: PF-08634404

Sites in Austin, Waco +107 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Sites in Austin, San Antonio +37 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for Melanoma

Sites in Austin, Houston +89 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for Endometrial Cancer

Sites in Austin, San Antonio +60 more locations

Sponsor: Genmab

Sex: Female·Age: 18+

Code: NCT07166094·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for Carcinoma, Non-Small-Cell Lung

Drug: Amivantamab

Sites in Austin, San Antonio +123 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for Renal Cell Carcinoma (RCC)

Sites in Austin, Dallas +42 more locations

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022

Apply to this trial

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for Large B-cell Lymphoma

Sites in Austin, San Antonio +34 more locations

Sponsor: Lyell Immunopharma, Inc.

Sex: All·Age: 18+

Code: NCT07188558·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for Cervical Cancer

Sites in Austin, Waco +126 more locations

Sponsor: Pfizer

Sex: Female·Age: 18+

Code: NCT06952660·Phase 4·Recruiting·Listed May 2025

Apply to this trial

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

Sites in Austin, San Antonio +122 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for Carcinoma, Non-Small-Cell Lung

Drug: LY3537982

Sites in Austin, Houston +86 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for Large B-cell Lymphoma

Sites in Austin, San Antonio +59 more locations

Sponsor: Allogene Therapeutics

Sex: All·Age: 18+

Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for NSCLC (Non-small Cell Lung Cancer)

Drug: daraxonrasib

Sites in Austin, The Woodlands +41 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT06881784·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for Chronic Lymphocytic Leukemia

Drug: Nemtabrutinib

Sites in Austin, San Antonio +41 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06136559·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for Solid Tumors

Sites in Austin, San Antonio +40 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018

Apply to this trial

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for Breast Cancer

Sites in Austin, San Antonio +47 more locations

Sponsor: Greenwich LifeSciences, Inc.

Sex: All·Age: 18 - 100

Code: NCT05232916·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for Advanced Cancer

Sites in Austin, San Antonio +36 more locations

Sponsor: Artios Pharma Ltd

Sex: All·Age: 18+

Code: NCT04657068·Phase 1, Phase 2·Recruiting·Listed Dec 2020

Apply to this trial

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for PIK3CA Mutation

Sites in Austin, Temple +50 more locations

Sponsor: Relay Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06982521·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for Epithelial Ovarian Cancer

Sites in Austin, San Antonio +65 more locations

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT06890338·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for Breast Neoplasms

Sites in Austin, Houston +36 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06926868·Phase 2, Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for Ovarian Cancer

Drug: INCB123667

Sites in Austin, San Antonio +36 more locations

Sponsor: Incyte Corporation

Sex: Female·Age: 18 - 99

Code: NCT07023627·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for High Grade Epithelial Ovarian Cancer

Sites in Austin, Fort Worth +35 more locations

Sponsor: Genmab

Sex: All·Age: 18+

Code: NCT05579366·Phase 1, Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for Ovarian Cancer

Sites in Austin, San Antonio +33 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06824467·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

Sites in Austin, Houston +44 more locations

Sponsor: Celgene

Sex: Male·Age: 18+

Code: NCT06764485·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for Breast Cancer

Sites in Austin, Houston +100 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Etentamig

Sites in Austin, Houston +25 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT05650632·Phase 1·Recruiting·Listed Dec 2022

Apply to this trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for Non-Small Cell Lung Cancer

Drug: Ivonescimab

Sites in Austin, Houston +92 more locations

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for Upper Urinary Tract Urothelial Carcinoma

Sites in Austin, The Woodlands +21 more locations

Sponsor: UroGen Pharma Ltd.

Sex: All·Age: 18+

Code: NCT06774131·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for HER2 Mutation-Related Tumors

Sites in Austin, Houston +27 more locations

Sponsor: Iambic Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06253871·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

for Follicular Lymphoma

Drug: Golcadomide

Sites in Austin, San Antonio +29 more locations

Sponsor: Celgene

Sex: All·Age: 18+

Code: NCT06911502·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for Chronic Lymphocytic Leukemia

Drug: Venetoclax

Sites in Austin, Dallas +29 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06428019·Phase 3·Recruiting·Listed May 2024

Apply to this trial

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for Gastroesophageal-junction Cancer

Sites in Austin, Houston +27 more locations

Sponsor: Shanghai Henlius Biotech

Sex: All·Age: 18+

Code: NCT06532006·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Austin, Houston +42 more locations

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT05735184·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for Breast Cancer

Sites in Austin, San Antonio +111 more locations

Sponsor: Agendia

Sex: All·Age: 18+

Code: NCT03053193·Recruiting·Listed Feb 2017

Apply to this trial

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for Advanced Solid Tumor

Sites in Austin, San Antonio +29 more locations

Sponsor: PMV Pharmaceuticals, Inc

Sex: All·Age: 12+

Code: NCT04585750·Phase 1, Phase 2·Recruiting·Listed Oct 2020

Apply to this trial

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

for Advanced Solid Tumors

Sites in Austin, Dallas +26 more locations

Sponsor: DualityBio Inc.

Sex: All·Age: 18+

Code: NCT05914116·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

Prospective Study to Assess a Diagnostic Aid for Cancer

for Cancer

Sites in Austin, Huntsville +33 more locations

Sponsor: Harbinger Health

Sex: All·Age: 45+

Code: NCT07046260·Recruiting·Listed Jul 2025

Apply to this trial

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for Pancreatic Cancer

Drug: Atebimetinib

Sites in Austin, San Antonio +35 more locations

Sponsor: Immuneering Corporation

Sex: All·Age: 18+

Code: NCT07562152·Phase 3·Recruiting·Listed May 2026

Apply to this trial

Top Research Study Locations in Austin

Researchers run research studies in Austin, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
Dell Children's Medical Center of Central Texas	Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome	33
The University of Texas at Austin	Attention Deficit Hyperactivity Disorder, Healthy, Multiple Sclerosis	23
University of Texas at Austin	Stroke, Alcohol Drinking, Alzheimer Disease	23
FutureSearch Trials of Neurology	Osteoarthritis, Knee, Chronic Pain, Migraine	14
GSK Investigational Site	HIV Infections, Non-alcoholic Fatty Liver Disease, Asthma	13
Texas Cardiac Arrhythmia Research Foundation	Atrial Fibrillation, Heart Failure, Paroxysmal AF	12
Dell Children's Medical Center	AAOCA, Acute Treatment of Migraine, Adolescent Idiopathic Scoliosis	11
Austin Clinical Trial Partners	Major Depressive Disorder, Depression, Generalized Anxiety Disorder	10
Austin Heart	Heart Failure, Obesity, Heart Failure With Preserved Ejection Fraction	10
Urology Austin	Prostate Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Bladder (Urothelial, Transitional Cell) Cancer	10
Texas Oncology - Central South	Advanced Renal Cell Carcinoma, Advanced Solid Tumor, Advanced or Metastatic Renal Cell Carcinoma	9
NEXT Austin	Advanced Solid Tumors, Endometrial Cancer, Advanced Solid Tumor	9
Texas Oncology - Central/South Texas	Acinar Cell Carcinoma, Advanced Cancer, Advanced Non-Small Cell Lung Cancer	8
National Neuromuscular Research Institute	Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Generalized Myasthenia Gravis	8
Austin Retina Associates	Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD), Age-related Macular Degeneration (AMD)	7
St. David's South Austin Medical Center	AML, MDS, Multiple Myeloma	7
Texas Oncology	Any Solid Oral Medication, CRC (Colorectal Cancer), HER2-low Hormone Receptor Positive Breast Cancer	7
Ascension Texas Cardiovascular	Aortic Valve Stenosis, Cardiovascular Diseases, Pulmonary Hypertension	6
IMA Clinical Research Austin	Obesity, Overweight, Liver Fibrosis	6
NEXT Oncology	Locally Advanced (Unresectable) or Metastatic Solid Tumors, Ovarian Cancer, Solid Tumor	6
University of Texas	Logopenic Progressive Aphasia, Logopenic Progressive Aphasia (LPA), Logopenic Variant Primary Progressive Aphasia	6
Austin Neuromuscular Center	Antiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP)	5
Austin Clinical Research, LLC	Diabetic Macular Edema, Geographic Atrophy, Macular Edema	5
Dell Children's Blood and Cancer Center	Neuroblastoma, Medulloblastoma, Pediatric Cancer	5
Dell Seton Medical Center at The University of Texas	Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8	5

Active & Upcoming Studies in Austin (2026)

Recruiting trials in Austin grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Common conditions studied in Austin

Obesity (22 active studies)
Overweight (17 active studies)
Heart Failure (16 active studies)
Endometrial Cancer (13 active studies)
Breast Cancer (12 active studies)
Schizophrenia (12 active studies)

Leading research sponsors in Austin

University of Texas at Austin
AbbVie
AstraZeneca
Children's Oncology Group
Eli Lilly and Company

Frequently asked questions

How many paid clinical trials are currently recruiting in Austin?

There are approximately 683 recruiting clinical trials in Austin, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Austin pay participants?

Most recruiting trials in Austin compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Austin?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Austin?

The most common conditions under active study in Austin include Obesity (22), Overweight (17), Heart Failure (16), Endometrial Cancer (13), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Austin?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Austin on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Austin?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Austin?

Recruiting research sites in Austin include Dell Children's Medical Center of Central Texas, The University of Texas at Austin, University of Texas at Austin, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Austin right now?

The largest active categories in Austin are Cancer & tumors (172), Neurology & pain (51), Diabetes & metabolic (50). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Other cities in Texas

Houston, TX(3,050)Dallas, TX(1,553)San Antonio, TX(991)Fort Worth, TX(321)El Paso, TX(183)Plano, TX(168)Tyler, TX(159)Sugar Land, TX(130)Irving, TX(118)The Woodlands, TX(110)Lubbock, TX(104)Bellaire, TX(100)Galveston, TX(82)Amarillo, TX(80)Richardson, TX(77)McAllen, TX(71)McKinney, TX(71)Temple, TX(69)Arlington, TX(64)DeSoto, TX(64)Webster, TX(62)Corpus Christi, TX(61)Mesquite, TX(60)Katy, TX(54)Waco, TX(52)Tomball, TX(49)Abilene, TX(48)Beaumont, TX(46)Round Rock, TX(45)Kingwood, TX(44)Cypress, TX(43)Conroe, TX(41)Lewisville, TX(41)Baytown, TX(39)Edinburg, TX(39)League City, TX(39)Denton, TX(38)Frisco, TX(36)Southlake, TX(36)Denison, TX(33)Harlingen, TX(31)Humble, TX(31)Mansfield, TX(31)Wichita Falls, TX(30)Shavano Park, TX(29)Weslaco, TX(29)Allen, TX(28)Brownsville, TX(28)Georgetown, TX(25)Richmond, TX(24)Longview, TX(22)Sherman, TX(22)Carrollton, TX(21)College Station, TX(21)Fort Sam Houston, TX(21)Flower Mound, TX(20)Garland, TX(19)Cedar Park, TX(18)Pasadena, TX(18)Bedford, TX(17)

Related healthcare resources in Texas

Latest Austin, TX clinical trials research report

Trials by condition in Austin

Obesity· 22 Heart Failure· 16 Endometrial Cancer· 13 Breast Cancer· 12 Schizophrenia· 12 Ovarian Cancer· 11

Conditions in Oncology (Austin, TX)

Solid tumor· 24 Non-small cell lung cancer (NSCLC)· 22 Breast cancer· 13 Endometrial cancer· 13 Cancer (any)· 12 Ovarian cancer· 11 Head and neck cancer· 8 Triple-negative breast cancer· 7 Pancreatic cancer· 7 Prostate cancer· 7 Multiple myeloma· 7 Colorectal cancer· 6 Cervical cancer· 6 Acute myeloid leukemia (AML)· 6 Bladder cancer· 5 Fallopian tube cancer· 5 Neuroblastoma· 5 Lung cancer· 4 Gastric cancer· 4 Metastatic prostate cancer· 4 Non-Hodgkin lymphoma· 4 HER2-negative breast cancer· 3 Small cell lung cancer· 3 Metastatic colorectal cancer· 3 Chronic lymphocytic leukemia (CLL)· 3 Leukemia (other)· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 HER2-positive breast cancer· 2 Rectal cancer· 2 Esophageal cancer· 2 Liver cancer· 2 Kidney cancer· 2 Uterine cancer· 2 Follicular lymphoma· 2 Small lymphocytic lymphoma· 2 Hematologic malignancy· 2 Melanoma· 2 Metastatic breast cancer· 1 Colon cancer· 1 Glioblastoma· 1 Brain cancer· 1 Acute lymphoblastic leukemia· 1 Myelodysplastic syndromes (MDS)· 1 Myeloproliferative neoplasm· 1 Hodgkin lymphoma· 1 Thyroid cancer· 1 Sarcoma· 1 Osteosarcoma· 1 Rhabdomyosarcoma· 1 Pediatric cancer· 1 Mesothelioma· 1 Neuroendocrine tumors· 1

Oncology Clinical Trials in Austin, TX

Newly added in Austin

119 clinical trials for Oncology

Top Research Study Locations in Austin

Active & Upcoming Studies in Austin (2026)

Cancer & tumors (172 active studies)

Neurology & pain (51 active studies)

Diabetes & metabolic (50 active studies)

Mental health & behavior (49 active studies)

Cardiovascular (44 active studies)

Eye & vision (23 active studies)

Pediatric (12 active studies)

Vaccines (4 active studies)

HIV / STI (4 active studies)

Common conditions studied in Austin

Leading research sponsors in Austin

Frequently asked questions

How many paid clinical trials are currently recruiting in Austin?

Do clinical trials in Austin pay participants?

Who can participate in a clinical trial in Austin?

What conditions are most commonly studied in Austin?

Are there clinical trials for healthy volunteers in Austin?

How do I enroll in a clinical trial in Austin?

Where can I take part in paid clinical trials in Austin?

What kinds of studies are recruiting in Austin right now?

Browse more clinical trials

Other cities in Texas

Related healthcare resources in Texas

Trials by condition in Austin

Conditions in Oncology (Austin, TX)